Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
, 9 (6), 694-9

Cytokines in Childhood Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura

Affiliations
Clinical Trial

Cytokines in Childhood Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura

D Karpman et al. Pediatr Nephrol.

Abstract

Serum and urine cytokines were analyzed in children with hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Interleukin-6 (IL-6) was elevated in the serum of 33 of 35 children with HUS (94%) and in 2 of 2 children with recurrent TTP. Serum IL-6 was higher in children with HUS who developed anuria, extrarenal manifestations during the acute phase of illness and/or chronic renal sequelae. Tumor necrosis factor-alpha (TNF-alpha) was detected in the serum of 7 patients with HUS (20%) and 1 patient with TTP. IL-6 and TNF-alpha were elevated in the urine of 4 of 4 children with HUS and 2 of 2 children with TTP. Urinary levels were higher than serum levels, suggesting local production of cytokines in the urinary tract. Sequential serum and urine samples showed that IL-6 levels varied with disease activity. IL-6 and TNF-alpha were not detected in the serum (n = 25) and urine (n = 15) of healthy children. We conclude that IL-6 in urine may be used to monitor disease activity in HUS and TTP.

Similar articles

See all similar articles

Cited by 30 articles

See all "Cited by" articles

References

    1. Clin Nephrol. 1992 Oct;38(4):185-9 - PubMed
    1. FASEB J. 1990 Aug;4(11):2860-7 - PubMed
    1. Infect Immun. 1991 Nov;59(11):4173-9 - PubMed
    1. Pediatrics. 1987 Jan;79(1):1-25 - PubMed
    1. J Immunol Methods. 1986 Dec 4;95(1):99-105 - PubMed

Publication types

LinkOut - more resources

Feedback